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Dendritic cells is not required for 
the immunomodulatory effects of 
the edible Mushroom Agaricus 
subrufescens
 
Ruud H. P. Wilbers, Lotte B. Westerhof, Jan van de Velde†, Geert Smant,  
Debbie R. van Raaij, Anton S. M. Sonnenberg, Jaap Bakker and Arjen Schots*
Plant Sciences Group, Wageningen University and Research Centre, Wageningen, Netherlands
Mushrooms are well known for their immunomodulating capacities. However, little is 
known about how mushroom-stimulated dendritic cells (DCs) affect T cells. Therefore, 
we investigated the effect of mushroom compounds derived from seven edible 
mushroom species on DCs, their fate in DCs, and the effect of the mushroom-stimulated 
DCs on T cells. Each mushroom species stimulated DCs in a different manner as was 
revealed from the DC’s cytokine response. Assessing DC maturation revealed that only 
one mushroom species, Agaricus subrufescens, induced complete DC maturation. 
The other six mushroom species upregulated MHC-II and CD86 expression, but did 
not significantly affect the expression of CD40 and CD11c. Nevertheless, mushroom 
compounds of all investigated mushroom species are endocytosed by DCs. Endocytosis 
is most likely mediated by C-type lectin receptors (CLRs) because CLR binding is Ca2+ 
dependent, and EGTA reduces TNF-α secretion with more than 90%. Laminarin partly 
inhibited TNF-α secretion indicating that the CLR dectin-1, among other CLRs, is involved 
in binding mushroom compounds. Stimulated DCs were shown to stimulate T cells; 
however, physical contact of DCs and T cells is not required. Because CLRs seem to 
play a prominent role in DC stimulation, mushrooms may function as a carbohydrate 
containing adjuvant to be used in conjunction with anti-fungal vaccines.
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inTrODUcTiOn
The functioning of the immune system may be impaired as a consequence of dietary deficiencies or 
imbalances and may thereby negatively impact health. Edible mushrooms are appreciated as health 
promoting food, notably having antitumor and immunomodulatory effects (1, 2). Mushrooms 
contain compounds that stimulate the immune system as well as prevent or cure infectious diseases, 
cancer, allergies, autoimmune, and inflammatory disorders (3–5). Various compounds including 
polysaccharides, mainly α- and β-glucans, saccharopeptides, (glyco)proteins, and various low 
molecular weight compounds such as terpenes and phenols, contribute to these medicinal effects (2, 
6). Of these compounds the role of β-1,3-glucans with β-1,6 branches is best documented, although 
the role of other compounds is increasingly appreciated (3, 4, 6, 7).
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Immunomodulation by mushrooms mainly takes place 
through macromolecules that function as pathogen-associated 
molecular patterns (PAMPs). Pattern recognition receptors 
(PRRs) on innate immune cells recognize these PAMPs, and these 
innate cells may subsequently interact with adaptive immune 
cells. Different classes of PRRs such as toll-like receptors (TLRs), 
complement receptor 3 (CR3), and C-type lectin receptors 
(CLRs) play a role in recognizing mushroom PAMPs (2, 8–10). 
The macromolecular composition of mushrooms is complex, and 
consequently, different classes of PRRs are involved in binding dif-
ferent PAMPs. TLRs bind glyco- and/or lipoproteins, CR3 binds 
β-glucan, whereas CLRs bind molecules carrying glyco-moieties 
such as glycoproteins, mannans, and glucans (10–12). The mix-
ture of compounds likely results in the simultaneous binding of 
different PRRs, leading to additive and possibly even synergistic 
effects (13). Dendritic cells (DCs) play a key role in recognizing 
PAMPs and subsequent immune signaling. Immature DCs are 
sentinel cells of the innate immune system that upon recogni-
tion and endocytosis of PAMPs mature and instruct the adaptive 
immune system, notably T cells, to undertake action. Upon anti-
gen presentation, MHC-II and costimulatory molecules on DCs 
bind T cells. This feature combined with DC-secreted cytokines 
leads to differentiation and proliferation of T-cell subsets such as 
T helper (Th)-1, Th-2, and Th-17 cells (4, 14). The exact role that 
different mushroom compounds play in DC–T cell interactions 
remains unclear.
Edible mushrooms are non-invasive fungi that exert their 
immune effect in the absence of pathogenesis. Mushroom 
PAMPs may be recognized by DCs guarding the lumen of the 
gut, the lamina propria upon passing the mucosal epithelium or 
elsewhere in the body when digested compounds enter circula-
tion. Regardless of the location where mushroom PAMPs are 
recognized, little is currently known about the modus operandi of 
mushroom immunomodulation, notably the effect on DCs and 
T cells. The aim of this study is to compare the immunomodula-
tory capacity of several mushroom species that have been reported 
to have an effect on the immune system. Thereto we compared the 
effect of seven edible mushroom species on ex vivo immune cells. 
We first assessed the composition of these mushroom species 
and their ability to stimulate DCs. Next, we studied endocytosis 
of mushroom compounds when presented to DCs and assessed 
the role of carbohydrate binding PRRs. Subsequently, we studied 
how mushroom compound challenged DC’s affect T cells. It is 
ultimately shown that mushrooms can aid in polarizing T-cell 
differentiation; however, physical interaction between DCs and 
T cells is not required. These new insights are useful for applying 
immunomodulatory mushrooms to promote health. This may 
be achieved by strengthening the immune system in general as 
well as in strategies to combat microbial infections for instance 
by using mushrooms as adjuvant.
MaTerials anD MeThODs
Mushroom extracts
All mushrooms were obtained from V.O.F. de Rijk-Stenssen 
(Rossum, The Netherlands). Mushrooms were harvested, directly 
transported to our laboratory, and frozen at −20°C. The frozen 
mushrooms were lyophilized and ground to a fine powder that 
was used as a complete homogenate (CH) in the experiments 
described. Part of the CH was alcohol precipitated to obtain a 
fraction enriched in polysaccharides according to Ng and Yap 
(15). Briefly, hot water extraction was performed for 20 min at 
121°C in an autoclave on CH followed by overnight precipita-
tion (4°C) with 70% ice-cold ethanol. The ethanol precipitate 
was removed by centrifugation, lyophilized, and subjected to a 
second hot water extraction. The second hot water extract was 
centrifuged and the supernatant was subjected to overnight pre-
cipitation with 50% ethanol at 4°C. The precipitate was collected 
by centrifugation (3500 × g, 30 min), lyophilized and ground to a 
fine powder, stored at −20°C, and used as an alcohol-precipitated 
polysaccharide fraction in the experiments described. For stimu-
lations, CH and AP were dissolved in PBS in a concentration of 
25 mg/ml.
cell culture
Bone marrow was obtained from the femur and tibia of 6- to 
12-week-old C57BL/6 mice. Bone marrow-derived dendritic cells 
(BMDCs) were differentiated for 10 days as previously described 
(16) using 10% spent medium from murine GM-CSF-transfected 
X63 cells (17). X63-GM-CSF cells were kindly provided by Dr. 
M. Lutz (University of Erlangen-Nuremberg, Germany) with 
approval of Dr. B. Stockinger (Francis Crick Institute, London, 
UK). Bone marrow cells were plated at 2 × 105 cells/ml in bac-
teriological petri dishes (Greiner Bio-One, Alphen aan de Rijn, 
The Netherlands) and incubated at 37°C/5% CO2. At days 3, 6, 
and 8, medium was refreshed, and at day 10, both adherent and 
non-adherent cells were harvested. At this time, typically 90–95% 
of the cells expressed the DC markers CD11c and MHC class II as 
assessed by flow cytometry.
T cells were obtained from spleens of 6- to 12-week-old C57BL/6 
mice. Isolation of the CD4+ T cells was done via the MagCellect 
Mouse CD4+ T Cell Isolation kit (R&D systems, Minneapolis, 
MN, USA) according to the manufacturer’s protocol.
Bone marrow-derived dendritic cells (5 × 105 cells/ml) were 
stimulated in a 96-well plate (Greiner Bio-One) for 24 h upon 
addition CH or AP of different mushroom species to a final 
concentration of 250 μg/ml. Curdlan and zymosan were used as 
control stimulants in a final concentration of 50 μg/ml and 1 mg/
ml, respectively. In CLR neutralization studies, 5  mM EGTA 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) or 250  μg/ml 
laminarin (Sigma) was added 30 min prior to stimulation with 
the CH of different mushroom species. In a coculture of BMDCs 
(105 cells/ml) and total T cells (5 × 105 cells/ml) in 96-well plates, 
BMDCs were stimulated for 24 h where after T cells were added. 
Costimulation was done for 7 days.
The coculture in ThinCerts using 24-well plates (Greiner Bio-
One) was done with 200 μg/ml CH, 250 μl DCs (2 × 105 cells/ml) 
and 250 μl T cells (1 × 106 cells/ml). During this experiment, there 
were two different setups. The control setup allowed the physi-
cal interaction between DCs and T cells, whereas the test setup 
did not. In both cases, a semipermeable membrane (ThinCert, 
3 μm pore size, Greiner Bio-One), that allowed the exchange of 
medium and cytokines but not cells, was used. T cells were added 
24 h after DC stimulation. In the test setup, the T cells were put 
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into the “membrane cup” instead of in the well to avoid migration 
of DCs toward the T cells.
Determination of Mushroom composition
Mushroom α- and β-glucan composition was determined using 
a β-Glucan (yeast and mushroom) Assay Kit (Megazyme, Bray, 
Ireland) according to the manufacturer’s protocol. The amount 
of protein in the mushroom preparations was determined using 
a BCA protein assay (Life Technologies Europe BV, Bleiswijk, 
The Netherlands). Polyphenols were determined using a Folin 
Ciocalteu assay. Thereto, 30 μl Folin Ciocalteu’s phenol reagent 
(Sigma) was added to 15 μl sample. This was incubated for 7–8 min 
where after 75 μl of a solution of 20% anhydrous Na2CO3 was 
added. The amount of polyphenol was determined by measuring 
the absorbance at 550  nm using a standard line of gallic acid. 
Chitin content was determined as reported (18). In short, freeze 
dried mushrooms were heated using a water bath for 2 h in 1 M 
NaOH under continuous stirring. The sample was filtered and 
washed with distilled water. The procedure was repeated for 3 h 
using saturated KOH. The samples were centrifuged at 8000 × g, 
the pellet washed with distilled water, lyophilized and dissolved 
in 10% acetic acid, and heated at 100°C for 1 h. Of each sample, 
2 μl was spotted on a thin layer plate (Polygram Sil G 0.2 mm, 
Macherey Nagel, Düren, Germany). The spots were detected with 
1% Lugol’s solution, after color formation the plates were dried 
with hot air. The density was analyzed from an image using Image 
J. A dilution series of chitin (Sigma) was used as reference.
cytokine elisa
TNF-α, Interleukin (IL)-6, IL-10, IL-12, IL-17, and IFN-γ levels 
in cell culture supernatants were determined using sandwich 
enzyme linked immunosorbent assay (ELISA) with ELISA 
Ready-Set-Go! Sets (eBioscience, Vienna, Austria) according to 
the supplier’s protocols.
Flow cytometry
Bone marrow-derived dendritic cells were stained in FACS buffer 
(PBS containing 0.1% bovine serum albumin and 5 mM EDTA) 
using the following monoclonal antibodies in the indicated 
concentration for cell surface markers (all obtained from eBio-
science): PE-conjugated anti-CD86 (2 μg/ml), FITC conjugated 
anti-CD-40 (5 μg/ml), PE-conjugated anti-CD11c (1 μg/ml), and 
APC-conjugated MHC-II (0.28 μg/ml). Cells were first incubated 
with Fc receptor block, 5 μg/ml (eBioscience) for 10 min to block 
any non-specific binding and subsequent staining steps were per-
formed for 20 min at 4°C, followed by washing with FACS buffer. 
An isotype-matched control staining was done for each antibody 
to determine a specific background staining. Cells were acquired 
using a Cyan-ADP cytometer (Beckman Coulter, Woerden, The 
Netherlands) and analyzed with FlowJo software (FlowJo LLC, 
Ashland, OR, USA).
analysis of Polysaccharide endocytosis by 
Flow cytometry and confocal Microscopy
Polysaccharides from alcohol-precipitated preparations were 
labeled with Alexa Fluor 488 hydrazide (Invitrogen, Life 
Technologies) according to the manufacturer’s protocol. Binding 
of the labeled mushroom compounds to BMDCs was first assessed 
using flow cytometry using 5 × 105 cells/ml and 5 μg/ml-labeled 
polysaccharides. Cells were acquired using a Cyan-ADP cytom-
eter (Beckman Coulter). Next, endocytosis of polysaccharides 
was visualized by seeding BMDCs on borosilicate chambered 
coverglasses at a density of 5 × 104 cells/chamber followed by incu-
bation with Alexa Fluor 488-labeled stimulants (10 μg/ml-labeled 
polysaccharides of Agaricus subrufescens or Lentinula edodes). As 
a positive control, 10 μg/ml FITC-labeled dextran (Sigma) was 
used. Unstimulated cells were used as a negative control. After 
6  h, the stimulants were removed by refreshing the medium. 
Confocal images were taken 24 h after the start of stimulation. 
Plasma membranes were stained with Cellmask Deep Red plasma 
membrane stain (Invitrogen, Life Technologies) and lysosomes 
with Lysotracker Red DND-99 (Invitrogen, Life Technologies). 
Imaging was done using an Axiovert LSM510 confocal micro-
scope (Carl Zeiss, Sliedrecht, The Netherlands) using a water 
objective C-Apochromat 40×. Images were processed using the 
LSM Image browser (Carl Zeiss), release 4.2.
statistical analysis
For statistical analysis, independent-samples T test was used. 
Analysis was carried out using SPSS version 22 (IBM corporation, 
Armonk, NY, USA).
resUlTs
composition of Mushroom extracts
Before assessing immunomodulatory effects of CHs and alcohol 
precipitates (APs) of the seven mushroom species under inves-
tigation the amounts of protein, α- and β-glucan, chitin, and 
polyphenol were assessed as percentage dry weight (Table 1). The 
obtained results emphasize a great variety in composition between 
the different mushroom species. The chitin and polyphenol 
contents remained below 5% (w/w) for all preparations, whereby 
chitin was never detected in AP. Because chitin is insoluble and 
the procedure included a centrifugation step, this result was to 
be expected. The polyphenol contents increased upon ethanol 
precipitation for A. subrufescens, L. edodes, and Hypsizygus tes-
sellatus. This result may indicate that these three species contain 
relatively high amounts of polyphenol/polysaccharide complexes 
or that the composition of the polyphenols differs. In the other 
four species, such complexes may still be present but to a much 
lower extent.
The amounts of protein, α-, and β-glucan varied between 
preparations and between species. Pholiota nameko contained 
the highest amounts of β-glucan in the CH; however after 
ethanol precipitation, both the α- and β-glucan content was 
reduced. This is in contrast to what was expected as upon 
ethanol precipitation the glucan fraction is often enlarged 
which was the case for all other preparations. The most striking 
effect of the ethanol precipitation was seen for H. tessellatus and 
Pleurotus eryngii where the total amount of glucan increased 
from, respectively, 45 and 40% to around 80% of the dry weight. 
Upon ethanol precipitation, the protein content decreased in five 
of the seven species; only for P. nameko and Grifola frondosa, 
the protein content increased. This may be caused by a relative 
TaBle 1 | Mushroom composition.
Protein 
%
Total glucan 
%
α-glucan 
%
β-glucan 
%
chitin 
%
Polyphenol 
%
A. subrufescens CH 18.2 12.8 0.6 12.2 2.3 0.9
AP 5.5 40.0 8.2 31.8 0 2.1
G. frondosa CH 19.3 10.4 2.5 7.9 ND 4.4
AP 24.5 38.5 10.3 28.2 ND 1.0
L. edodes CH 5.8 21.4 1.5 19.9 1.97 2.3
AP 0.0 34.2 7.0 27.2 0 4.3
H. tessellatus CH 5.3 36.6 5.2 31.3 0.54 1.4
AP 0.0 81.8 11.3 70.5 0 2.1
P. eryngii CH 12.9 37.6 1.6 36.0 4.67 0.4
AP 1.6 78.1 13.0 65.1 0 0.2
P. nameko CH 9.0 59.5 1.4 58.1 1.32 3.3
AP 11.7 36.8 0.9 35.9 0 0.3
P. ostreatus CH 15.6 32.9 1.3 31.6 1.02 2.1
AP 2.3 36.6 9.6 27.0 0 1.0
The contents of protein, total glucan, α- and β-glucan, chitin, and polyphenol as percentage of the total dry weight are given. ND is not determined.
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high amount of saccharopeptides present in these species. In 
the AP of L. edodes and H. tessellatus, no protein was detected. 
This result could indicate that in these two species no protein is 
bound to polysaccharides that are precipitated with ethanol. All 
in all, protein as well as α- and β-glucan contents vary greatly 
between species.
extracts from Different Mushrooms 
species lead to a Differential cytokine 
secretion Pattern in Dendritic cells
To determine the effect of mushroom compounds on cytokine 
expression by DCs, CH or AP of each of the seven mushroom 
species was added to DCs. ELISA was used to measure the 
effect on the secretion of cytokines TNF-α, IL-6, IL-10, and 
IL-12 (Figures  1A–D, respectively). In the control experi-
ments, the expression of TNF-α, IL-6, and IL-12 remained 
below detection level. All preparations induced expression of 
the pro-inflammatory cytokines TNF-α and IL-6. H. tessellatus 
can be considered as the worst inducer of these cytokines. 
The CH of H. tessellatus induced TNF-α secretion in low 
amounts, which was almost absent upon stimulation with AP. 
H. tessellatus CH and AP hardly induced secretion of any of 
the other cytokines measured. It is worth noting that alcohol 
precipitation of H. tessellatus CH lead to the largest increase of 
glucan content, notably β-glucans (Table  1), whereas protein 
was absent in AP. Apparently, the H. tessellatus glucans cannot 
be considered as strong immunomodulators. Secretion of the 
anti-inflammatory cytokine IL-10 was significantly induced by 
CH of A. subrufescens, G. frondosa, and Pleurotus ostreatus. Of 
the AP preparations, only A. subrufescens significantly induced 
IL-10. Strikingly, the three species that induce IL-10 secre-
tion show the highest protein content of all CH preparations 
(Table 1). Expression of the Th-1-inducing cytokine IL-12 was 
induced by A. subrufescens (CH and AP), G. frondosa (CH 
and AP), and P. nameko (AP). All other preparations induced 
IL-12 to concentrations <100 pg/ml. Considering all cytokines, 
alcohol precipitation, to enrich the polysaccharide fraction, 
affects the secretion of cytokines only to a minor extent. Only 
for G. frondosa, H. tessellatus, and P. nameko, the induction of 
TNF-α expression, and for P. ostreatus, the induction of IL-12 
expression differed significantly between the CH and AP prepa-
rations (Figure 1). The seven species investigated have all been 
reported to immunomodulate. It was surprising to observe that 
L. edodes and P. eryngii, both species that have been reported to 
be strong immunomodulators, only moderately induced TNF-α 
and IL-6 secretion. In general, the extent to which the seven 
species investigated affect secretion of TNF-α, IL-6, IL-10, and 
IL-12 by DCs varies greatly and likely depends on the structure 
and composition of polysaccharide complexes either or not in 
combination with peptides/protein.
not all Mushroom species are Potent 
inducers of Maturation of Dendritic cells
The differences in cytokine responses and notably the low 
responses induced by several species prompted us to study the 
maturation of the DCs. Thereto, DCs were stimulated with AP of 
each of the seven mushrooms. After 24 h the cells were labeled 
with anti-CD11c-PE, anti-MHC-II-APC, anti-CD40-FITC, or 
anti-CD86-PE antibodies and the fluorescence intensity was 
measured with flow cytometry. The average mean fluorescence of 
three independent experiments is depicted in Figure 2. Untreated 
cells, incubated in tissue culture medium, showed a typical 
immature BMDC phenotype, i.e., CD11c+-CD40low-CD86low-
MHC-IIlow. Striking differences in the maturation state of the DCs 
stimulated with the AP from different mushrooms were observed. 
All mushrooms significantly upregulated MHC-II expression 
(Figure 2A). The expression of the costimulatory molecule CD40 
was only significantly affected by A. subrufescens AP and curdlan 
(Figure 2B). In the case of the costimulatory molecule CD86, all 
mushrooms except G. frondosa lead to significant upregulation 
(Figure 2C). It was noted that the extent of CD86 upregulation 
differed considerably between species. Upon maturation CD11c 
is expected to be downregulated. However, considerable down-
regulation of CD11c was only observed for A. subrufescens AP and 
curdlan, although not significant (Figure  2D). Taken together, 
these data reveal that compounds from different mushrooms 
FigUre 1 | The effect of mushroom compounds of seven mushroom species on cytokine secretion of bone marrow-derived dendritic cells. Both the 
effects of the complete homogenate (CH) and the alcohol precipitate (AP) were analyzed. Curdlan and zymosan were used as controls. Both the mushroom species 
and the preparation methods show a differential effect on cytokine secretion by dendritic cells. (a) Tumor necrosis factor α. (B) Interleukin-6. (c) Interleukin-10. (D) 
Interleukin-12. Asterisk (*) indicates significant difference between CH and AP responses (p < 0.05, n = 4–7). Hashtag (#) indicates significant differences between 
control and mushroom compounds with regard to IL-10 secretion (p < 0.05, n = 4–7).
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do affect DCs as revealed by the MHC-II and CD86 expression. 
However, CD11c and CD40 expression is much less affected. 
A. subrufescens is the most potent inducer of DC maturation.
Dendritic cells Bind and endocytose 
Mushroom compounds
Because of the variation in the extent of cytokine secretion 
and maturation, and notably the weak responses observed for 
H. tessellatus, L. edodes, and P. eryngii, we investigated whether 
or not mushroom compounds are recognized by DCs in all 
cases. To investigate this, Alexa Fluor 488-labeled mushroom 
compounds and FITC-labeled dextran as control were added to 
DCs. Because Alexa Fluor 488 hydrazide was used, it is expected 
that only polysaccharides and glycoproteins were labeled. Using 
flow cytometry we confirmed that labeled compounds from all 
mushrooms investigated as well as dextran bind DCs; however, 
the amounts vary considerably (Figure  3A). Using confocal 
microscopy, we confirmed that compounds of all mushrooms 
investigated are indeed endocytosed (Figure 3B). We next inves-
tigated endocytosis by DCs in more detail using A. subrufescens as 
the best responder and L. edodes as weak responder. The labeled 
mushroom compounds showed indeed to ultimately reside in 
the (endo-)lysosomes (Figure  3C). Both protein and glucan 
composition vary considerably as do the amounts that bind DCs 
(Figure 3A). Nevertheless, endocytosis was observed in all cases 
(Figure 3B). We therefore next investigated the role of CLRs as 
carbohydrate binding PRRs.
Prrs specific for carbohydrates Bind 
Mushroom compounds
Because mushrooms contain a substantial amount of car-
bohydrates that may function as PAMP the involvement of 
carbohydrate-specific PRRs in endocytosis seems plausible. 
CLRs and CR3 are major endocytosis receptors as well as an 
FigUre 3 | Dendritic cells endocytose mushroom compounds.
FigUre 2 | analysis of the maturation state of bone marrow-derived dendritic cells upon stimulation with compounds derived from seven mushroom 
species. Dendritic cells (DCs) were stimulated with alcohol-precipitated mushroom compounds and curdlan as control. After 24 h, the DCs were labeled with 
fluorescently labeled antibodies and analyzed with flow cytometry. The obtained mean fluorescence intensity (MFI) is indicated. Only upon stimulation with 
A. subrufescens, mature DCs are observed. Notably, the upregulation of CD40 and CD86 and the downregulation of CD11c vary. (a) Labeling with anti-CD11c-PE. 
(B) Labeling with anti-CD40-FITC. (c) Labeling with anti-MHC-II-APC. (D) Labeling with anti-CD86-PE. Asterisk (*) indicates significant difference with the medium 
control, i.e., unstimulated DCs (p < 0.05, n = 3).
(Continued)
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FigUre 3 | continued  
Alexa Fluor 488-labeled mushroom compounds were added to DCs and analyzed by flow cytometry and confocal microscopy. Fluorescent dextran was used as 
control. (a) Binding of fluorescently labeled mushroom compounds to DCs as analyzed by flow cytometry. (B) Endocytosis of fluorescent mushroom compounds of 
six mushroom species analyzed with confocal microscopy. (c) Endocytosis of fluorescent Agaricus subrufescens and Lentinula edodes compounds visualized using 
confocal microscopy (40× magnification). Plasma membranes and lysosomes were stained as indicated. The merged pictures reveal that labeled compounds are 
present in the endo-lysosomes of DCs.
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important carbohydrate binding class of PRRs that function in 
a calcium-dependent manner. The addition of a chelating agent 
inhibits carbohydrate binding to CLRs and CR3. To investigate 
CLR/CR3 involvement, DCs were therefore pre-incubated with 
the chelating agent EGTA, whereupon CH of six mushroom 
species (A. subrufescens, H. tessellatus, L. edodes, P. eryngii, 
FigUre 5 | Mushrooms stimulate T cells through Dcs; however, 
physical contact between these cells is not required. T cells were 
added to CH stimulated dendritic cells that were physically separated from 
each other or not. Seven days later the interferon-γ (IFN-γ) and interleukin-17 
(IL-17) response was measured. (a) Mushroom induced IL-17 response. (B) 
Mushroom induced IFN-γ response. (c) Regardless of whether or not T cells 
were physically separated from DCs (when placed in a ThinCert), the IFN-γ 
and IL-17 responses do not significantly differ.
FigUre 4 | c-type lectin receptors and notably dectin-1 bind 
mushroom compounds. Dendritic cells were pre-incubated with either the 
chelator EGTA or the low molecular weight soluble β-glucan laminarin 
followed by stimulation with mushroom compounds. The effect of EGTA and 
laminarin was assessed by measuring the effect on the TNF-α response. 
EGTA reduced the TNF-α response to 5–10% of the original response and 
laminarin showed an inhibition to 40–75%. The effect of EGTA indicates that 
this class of PRRs plays an important role in DC stimulation because C-type 
lectin receptors (CLRs) are calcium dependent. Laminarin is a dectin-1 
antagonist and shows that this CLR is involved in the binding of mushroom 
compounds.
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P. nameko, and P. ostreatus) was added. After 24 h, the TNF-α 
response was measured. EGTA inhibits the TNF-α response with 
90–95% (Figure 4). The inhibition of the cytokine response by 
EGTA suggests that mushroom compounds do indeed target 
CLRs and/or CR3.
β-Glucans are polymeric carbohydrates assumed to play an 
important role in immune stimulation by mushrooms through 
the CLR dectin-1 (2, 6). Laminarin is a low molecular weight 
water-soluble β-glucan that binds dectin-1 without stimulating 
downstream signaling, yet blocking binding of other β-glucans to 
dectin-1 (19). Pre-incubation of DCs with laminarin inhibits the 
TNF-α response with 25–60% (Figure 4). Therefore, we conclude 
that dectin-1 binding of β-glucans plays an important role in the 
stimulation of DCs by mushrooms. Dectin-1 is, however, not the 
only carbohydrate binding PRR involved as can be inferred from 
the differences in inhibition by laminarin.
Mushrooms stimulate a Mixed cD4+ 
T-cell response
Since mushroom compounds are endocytosed, induce cytokine 
secretion, MHC-II expression and in some cases expression 
of CD40 and CD86 molecules, we next assessed the effect of 
mushroom-stimulated DCs on T cells. Thereto, T cells were 
added to DCs that were stimulated for 24 h with CH of different 
mushrooms. After 7  days, the presence of the T-cell cytokines 
IFN-γ, IL-4, and IL-17 was assessed using ELISA. The incubation 
of T cells with mushroom extracts for 7 days never resulted in 
the secretion of IFN-γ, IL-4, and IL-17 (data not shown). In the 
cocultures, detectable levels of IL-4 were never measured (data 
not shown). However, secretion of IL-17 and IFN-γ (Figure 5) was 
stimulated by A. subrufescens, G. frondosa, L. edodes, P. nameko, 
and P. ostreatus, although secretion of IL-17 induced by L. edodes 
was low. IFN-γ and IL-17 are the signature cytokines for a Th-1 
and Th-17 response, respectively. These results suggest that 
mushrooms are capable of stimulating a mixed T-cell response, 
as seen for many pathogens. As mushrooms are (non-pathogenic) 
fungi, it was expected that a Th-17 response would prevail alike 
what has been shown for pathogenic fungi.
Physical contact between Dcs and T cells 
is not required to stimulate T cells
Although mushroom compounds can stimulate T cells through 
DCs, the question that remains is whether or not DCs process 
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endocytosed mushroom compounds and present fragments to 
T cells via MHC-II molecules. To date, only the zwitterionic 
polysaccharide A of Bacteroides fragilis has been shown to acti-
vate T cells in a MHC-II dependent manner (20). Other polysac-
charides stimulate the immune system in a T cell-independent 
manner. Since the preparations of mushroom compounds also 
contain protein, these may be presented to T cells via MHC-II 
molecules. If presentation through MHC-II molecules takes 
place, physical contact between DCs and T cells is required. An 
experiment was carried out wherein DCs and T cells were physi-
cally separated by using ThinCertTM membrane supports. DCs 
were stimulated with A. subrufescens CH for 24 h in a 24-well 
plate, when a ThinCertTM membrane support holding T cells was 
placed in the well. Simultaneously, DCs were incubated together 
with T cells in a 24-well plate. A. subrufescens was chosen for 
this experiment as this mushroom showed the strongest effect 
on DCs and T cells with regard to cytokine secretion as well 
as on the upregulation of the costimulatory molecules CD40 
and CD86. After 7 days, the secretion of IFN-γ and IL-17 was 
determined using ELISA. Physical contact between DCs and 
T cells was not necessary to stimulate T cells to secrete IFN-γ 
and IL-17 (Figure 5C). Hence, fragments of mushroom proteins 
likely do not mediate the stimulation of T cells as this would 
be mediated by MHC-II molecules. This result implies that 
(polymeric) mushroom carbohydrates activate DCs resulting in 
cytokine secretion that stimulate T cells.
DiscUssiOn
In this study, we evaluated the immunomodulatory effect of 
seven edible mushroom species on ex vivo immune cells. We 
used CHs, resembling mushrooms as part of the human diet, as 
well as APs of the CH. Alcohol precipitation generally increases 
the polymeric carbohydrate fraction, including glucans that have 
been identified as important immunomodulators (4). The secre-
tion of cytokines by DCs and CD4+ T cells was assessed as well 
as DC maturation and endocytosis of mushroom compounds 
by DCs. We demonstrated that the CH and AP of different 
mushroom species had varying effects on ex vivo cells, and that 
carbohydrate receptors (CLRs and CR3), notably dectin-1, are 
important PRRs in mushroom immune stimulation. Physical 
contact between DCs and T cells was not required to stimulate 
CD4+ T cells.
Variation in DC responses may be explained by differences in 
mushroom composition as well as by different compounds that, 
either or not in concert, affect immune cells. We determined 
the α- and β-glucan-, protein-, chitin-, and polyphenol-content 
as these compounds are known to have immunomodulatory 
effects. Nevertheless, the IL-6 and IL-10 responses of both CH 
and AP preparations were similar for all species. The fact that 
EGTA almost completely abolishes the TNF-α response indicates 
that carbohydrates play a dominant role in mushroom immu-
nomodulation. The TNF-α response of G. frondosa and H. tes-
sellatus differed significantly, with the CH preparations resulting 
in a stronger response than the AP preparations. In contrast, the 
TNF-α response of the AP of P. nameko and the IL-12 response 
of the AP of P. ostreatus were stronger than their respective 
CH preparations. P. nameko was the only mushroom for which 
alcohol precipitation did not increase the glucan content. Thus, 
for this species, the increase in polysaccharide content does not 
coincide with an increase in cytokine response.
Immunomodulating carbohydrate containing compounds 
found in mushrooms vary in structure and composition. 
Mushroom β-glucans are structurally diverse molecules varying 
in branching, through 1,6 linkages, and in molecular mass (21, 
22). β-Glucans with a degree of branching between 0.20 and 
0.33 seem to be the most active (23). It may well be that in the 
low-responding mushrooms investigated, the fraction of active 
β-glucans is low. It has been reported that many biotic and abiotic 
factors affect the synthesis and/or degradation and consequently 
the structure of β-glucans. In L. edodes, increased glucanase activ-
ity during storage affected the cytokine response of macrophages 
(24, 25). Genetic factors may also play a role as was shown for 
different strains of L. edodes that showed a different effect on 
inhibition of NO production by macrophages (26). The L. edodes 
mushrooms, highly appreciated for their immunomodulating 
properties, induced relatively low cytokine responses (Figure 1). 
This may be explained by variations in structure and composition 
of polysaccharides. Proteoglycans and glycoproteins are other 
molecules that contribute to immunomodulation by mushrooms. 
For A. subrufescens (also known as Agaricus blazei), water-soluble 
proteoglycan was reported to stimulate BMDCs (27). Also in our 
hands, A. subrufescens showed to be a strong immunomodulator 
that may well be caused by carbohydrate containing proteins. 
Taken together, the variation in mushroom compound structure 
and composition largely determines the immunomodulatory 
activities resulting in a distinct stimulation of immune cells.
Mushroom stimulation of DCs leads not only to distinct 
cytokine secretion patterns but also to distinct maturation states 
of DCs (Figure  2). The cytokine secretion patterns match the 
maturation state of DCs. Mushroom species that elicit poor 
cytokine responses also lead to reduced upregulation (MHC-II, 
CD40, CD86) or downregulation (CD11c) of maturation markers. 
It is well established that upon immune stimulation, a spectrum 
of maturation states of DCs is seen, varying from immature to 
semi-mature and mature (28). The maturation state is rather a 
phenotypic description than a functional description and does 
not necessarily coincide with the activation state of a DC (29). 
DCs that are phenotypically mature can still lead to highly vary-
ing T-cell responses. The activation state of a DC is determined by 
the combination of expressed membrane receptors and cytokines 
that lead to activation of T cells. In vivo the activation state of 
DCs is instigated by a combination of signals. These are signals 
received from PAMPs that bind PRRs, autocrine and paracrine 
effects of PRR induced cytokines, feedback signals from other 
innate, and adaptive immune cells as well as danger signals (30). 
Direct recognition of PAMPs by DCs is the crucial first step that 
is required to elicit proper T-cell responses. The other signals 
are merely amplification signals to ascertain that an immune 
response is of an appropriate magnitude (31). In the in vitro setup 
used in this study, ex vivo BMDCs are only stimulated by mush-
room PAMPs possibly combined with some autocrine cytokine 
stimulation. Paracrine signals are excluded, and the contribution 
of direct PRR signaling could be assessed. Hence, the differences 
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in activation state of the ex vivo DCs can only be caused by dif-
ferential binding of mushroom PAMPs to PRRs.
Polymeric carbohydrates, glycoproteins, and proteoglycans 
are important carbohydrate containing fungal immunomodula-
tors that mediate their effect by binding to different classes of 
PRRs (32). Most, if not all, of these compounds are important 
building blocks of the fungal cell wall and contain, next to glu-
cose, mannose and, to a minor extent, other carbohydrates such 
as galactofuran. By using EGTA, it was revealed that preparations 
of all mushroom compounds bind carbohydrate binding PRRs, 
i.e., CLRs and CR3 (Figure 4). As recently published, particulate 
β-glucans are required to activate dectin-1 (33). We showed that 
the low molecular weight and soluble β-glucan laminarin inhibits 
immunomodulation by mushroom compounds. This observa-
tion implies that the β-glucans in the mushroom preparations are 
of a particulate nature. Since EGTA and laminarin never com-
pletely reduced TNF-α responses, other than β-glucan mediated 
responses have to be considered as well. Mannose-containing 
compounds are also expected to be present in the preparations 
that we used, and they also bind CLRs such as the mannose recep-
tor, DC-SIGN, and galectins. Mannose is present in the glycans 
attached to proteins as well as in mannan, a fungal polysaccharide. 
Mannan containing compounds also bind TLR2 and TLR4, and 
likely TLR2/4 and TLR2/6 heterodimers (34). These TLRs have 
been reported to play a role in anti-fungal immunity (34). In vivo, 
the engagement of a ligand by a TLR is a prerequisite for DC mat-
uration (35). Mushrooms can induce activation of DCs through 
TLRs as was shown for Sparassis crispa and Phellinus linteus. For 
S. crispa, the involvement of TLR4 was shown (15), whereas for 
P. linteus, the involvement of TLR2 and TLR4 was proven (36, 
37). A. subrufescens was shown to bind TLR2 on THP-1 cells, 
and in the same study, the same preparation induced maturation 
of human monocyte derived DCs (38). Hence, a role for TLR2 
in the activation of DCs by A. subrufescens seems plausible. The 
complex nature of whole-mushroom extracts, combined with 
the fact that different PRRs play a prominent role, may well lead 
to additive or even synergistic effects as pointed out previously 
(13). In studies of the immune response against pathogenic fungi, 
synergistic effects have indeed been reported (34, 39).
The fact that MHC-II expression is upregulated by mushroom 
compounds raised the question what the effect of the mushroom-
stimulated DCs on CD4+ T cells is. In the DC–T-cell coculture 
experiments, five of the seven mushroom species stimulated the 
secretion of varying amounts of T-cell cytokines (Figure 5). Yet, 
we never observed any visible proliferation of T cells despite the 
fact that around 70% of the splenic CD4+ T cells were naïve 
(data not shown). Physical separation of DCs and T cells did not 
affect the results with regard to the secretion of IFN-γ and IL-17 
(Figure  5C). Apparently, as non-pathogenic microorganisms, 
mushrooms do not lead to antigen presentation even when DC 
activation is induced, as was the case for A. subrufescens. It is 
therefore somewhat puzzling that five of the seven mushrooms 
lead to the production of IFN-γ and IL-17. Bystander activation 
of resting T cells has been reported (40). In the presence of IL-2, 
TNF-α, and IL-6 resting T cells do show some proliferation, albeit 
still poor with only 3% of the cells growing. The amounts of IFN-γ 
and IL-17 produced by the T cells are congruent with the amounts 
of TNF-α and IL-6 produced by the DCs upon stimulation by 
the seven mushroom species. The minor proportion of splenic 
T cells that were already activated may well have produced the 
required IL-2 for the small, but imperceptible, number of T cells 
that proliferated in the coculture. This mechanism of antigen-
independent stimulation may explain why no contact between 
DCs and T cells is required. Even partially activated DCs, as 
seen for G. frondosa, L. edodes, P. nameko, and P. ostreatus, may 
contribute to a low level of bystander activation of T cells.
Taken together, we show that mushrooms can stimulate 
cells of the adaptive immune system without antigen presenta-
tion. Thus, mushrooms do not directly lead to T-cell activation 
through recognition of MHC-bound peptide by the antigen-
specific T-cell receptor, often referred to as signal 1. However, not 
only this signal 1 is required for the activation of naïve T cells. 
Co-stimulation (signal 2) through other membrane receptors as 
well as cytokines and growth factors that direct Th cell stimulation 
(signal 3) are also required. Our results show that mushrooms, 
depending on the species, can stimulate signals 2 and 3 through 
their binding to CLRs possibly in combination with TLRs. Thus, 
mushrooms that upregulate signal 2 and 3 may well function 
as an adjuvant. This mechanism may explain how mushrooms 
exert their immunomodulating effects. A vast amount of lit-
erature describes immunomodulating effects of mushrooms; 
however, the mechanisms that result in immunomodulation 
remain obscure. Our findings disclose such a mechanism and 
may explain how mushroom consumption affects the immune 
system. In South and East Asia, mushrooms are often consumed 
upon cancer treatment by chemotherapy and/or radiotherapy. 
Both cancer and its treatments are immunosuppressive; hence, 
immunostimulating agents may be useful as long as they do not 
interfere with the conventional therapy (41). Another possible 
advantage of the regular consumption of mushrooms may be the 
reduction or alleviation of food allergies. Oral administration of a 
protein isolated from the edible mushroom Flammulina velutipes 
inhibited the development of an allergic reaction to the model 
food (egg) allergen ovalbumin in mice (42). A similar result was 
obtained with an extract from A. subrufescens (also known as 
A. blazei) and ovalbumin allergy (43). The same mushroom also 
protected mice against pneumonia caused by Streptococcus pneu-
monia upon oral administration of a water extract. The examples 
show that as non-invasive fungi, mushrooms are recognized by 
the mucosal immune system and affect the innate and adaptive 
immune system in a system-wide manner.
Currently there is a need for new adjuvants that are safe and 
efficient. Adjuvants targeting CLRs as an alternative to or in 
concert with TLRs may be beneficial for vaccine efficacy (44, 45). 
Adjuvants based on carbohydrates are particularly useful in the 
development of anti-fungal vaccines. Curdlan, a 1,3-β-glucan, 
showed to be a useful adjuvant when combined with a novel 
Candida albicans epitope. This β-glucan polarized the immune 
response in the direction of a Th-17 response (46). In the defense 
against other fungi, a combined targeting of TLRs and CLRs is 
required as was shown for Fonsecaea pedrosoi causing chromo-
blastomycosis, a chronic skin infection (47). Next to the general 
immune stimulating properties ascribed to mushrooms, these 
examples show that mushrooms may be useful in treating specific 
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